| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| SDZ.SW - | HOLD | 0 @ CHF 67.0081 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 67.0081. The average price that SDZ.SW shares were previous bought at was CHF 47.9492. The current market price is 39.7% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 205,952 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 564.44 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 564.44. The average price that LONN.SW shares were previous bought at was CHF 603.654. The current market price is -6.5% lower than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 641,436 compared to the previous valuation of |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 121.45 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 121.45. The average price that MRK.DE shares were previous bought at was EUR 118.299. The current market price is 2.7% higher than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 566,737 compared to the previous valuation of Merck KGaA |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 39.5671 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 39.5671. The average price that NOVO-B.CO shares were previous bought at was DKK 54.1482. The current market price is -26.9% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 30,133,533 compared to the previous valuation of Novo Nordisk A/S |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 73.85 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 73.85. The average price that ORNBV.HE shares were previous bought at was EUR 60.2191. The current market price is 22.6% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 290,307 compared to the previous valuation of Orion Oyj however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 24.79 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 24.79. The average price that PHIA.AS shares were previous bought at was EUR 22.5066. The current market price is 10.1% higher than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 292,159 compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 47.2 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 47.2. The average price that REC.MI shares were previous bought at was EUR 52.4932. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 43,625 compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 398.12 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 398.12. The average price that RO.SW shares were previous bought at was CHF 308.354. The current market price is 29.1% higher than average price they were purchased at. The value of the holding in RO.SW has increased by CHF 148,986 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 388.953 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 388.953. The average price that ROG.SW shares were previous bought at was CHF 292.991. The current market price is 32.8% higher than average price they were purchased at. The value of the holding in ROG.SW has increased by CHF 2,751,948 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 80.36 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 80.36. The average price that SAN.PA shares were previous bought at was EUR 86.7193. The current market price is -7.3% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 89,604 compared to the previous valuation of Sanofi SA |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 136.1 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 136.1. The average price that IPN.PA shares were previous bought at was EUR 111.788. The current market price is 21.7% higher than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 44,317 compared to the previous valuation of Ipsen SA |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 41.4 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 41.4. The average price that SHL.DE shares were previous bought at was EUR 47.0975. The current market price is -12.1% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 287,427 compared to the previous valuation of Siemens Healthineers AG |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 14.5936 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 14.5936. The average price that SN.L shares were previous bought at was GBP 13.7289. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in SN.L has increased by GBP 103,270 compared to the previous valuation of Smith & Nephew PLC however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 37.1224 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 37.1224. The average price that SOBI.ST shares were previous bought at was SEK 27.0618. The current market price is 37.2% higher than average price they were purchased at. The value of the holding in SOBI.ST has increased by SEK 788,466 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 224.597 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 224.597. The average price that SOON.SW shares were previous bought at was CHF 259.181. The current market price is -13.3% lower than average price they were purchased at. The value of the holding in SOON.SW has fallen by CHF 103,248 compared to the previous valuation of |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 239.6 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 239.6. The average price that SRT3.DE shares were previous bought at was EUR 219.226. The current market price is 9.3% higher than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 113,947 compared to the previous valuation of Sartorius AG however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 108.697 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 108.697. The average price that STMN.SW shares were previous bought at was CHF 109.628. The current market price is -0.8% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 745,208 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| TUB.BR - Financiere de Tubize SA | HOLD | 0 @ EUR 225 | EUR 0 | The current share valuation price of TUB.BR based on adjusted close was EUR 225. The average price that TUB.BR shares were previous bought at was EUR 220.6. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in TUB.BR has increased by EUR 63,112 compared to the previous valuation of Financiere de Tubize SA however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 262 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 262. The average price that UCB.BR shares were previous bought at was EUR 193.596. The current market price is 35.3% higher than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 159,872 compared to the previous valuation of UCB SA however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 68 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 68. The average price that ERF.PA shares were previous bought at was EUR 58.3524. The current market price is 16.5% higher than average price they were purchased at. The value of the holding in ERF.PA has increased by EUR 34,091 compared to the previous valuation of Eurofins Scientific SE however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 695.6 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 695.6. The average price that ARGX.BR shares were previous bought at was EUR 591.546. The current market price is 17.6% higher than average price they were purchased at. The value of the holding in ARGX.BR has fallen by EUR 998,820 compared to the previous valuation of Argenx SE |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 162.453 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 162.453. The average price that AZN.L shares were previous bought at was GBP 133.626. The current market price is 21.6% higher than average price they were purchased at. The value of the holding in AZN.L has increased by GBP 278,516 compared to the previous valuation of AstraZeneca PLC however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 45.8 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 45.8. The average price that BAYN.DE shares were previous bought at was EUR 26.4621. The current market price is 73.1% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 705,306 compared to the previous valuation of Bayer AG however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 94.8 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 94.8. The average price that BIM.PA shares were previous bought at was EUR 113.695. The current market price is -16.6% lower than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 78,015 compared to the previous valuation of BioMerieux |
| COLO-B.CO - | HOLD | 0 @ DKK 66.079 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 66.079. The average price that COLO-B.CO shares were previous bought at was DKK 82.6943. The current market price is -20.1% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 658,510 compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 25.0926 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 25.0926. The average price that DEMANT.CO shares were previous bought at was DKK 32.2206. The current market price is -22.1% lower than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 406,285 compared to the previous valuation of |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 177.9 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 177.9. The average price that DIM.PA shares were previous bought at was EUR 193.813. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 247,354 compared to the previous valuation of Sartorius Stedim Biotech |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 255.1 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 255.1. The average price that EL.PA shares were previous bought at was EUR 263.653. The current market price is -3.2% lower than average price they were purchased at. The value of the holding in EL.PA has fallen by EUR 434,117 compared to the previous valuation of EssilorLuxottica SA |
| ALC.SW - | HOLD | 0 @ CHF 66.2878 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 66.2878. The average price that ALC.SW shares were previous bought at was CHF 73.5684. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 421,612 compared to the previous valuation of |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 40.64 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 40.64. The average price that FME.DE shares were previous bought at was EUR 45.5278. The current market price is -10.7% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 506,161 compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 49.76 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 49.76. The average price that FRE.DE shares were previous bought at was EUR 43.0226. The current market price is 15.7% higher than average price they were purchased at. The value of the holding in FRE.DE has increased by EUR 686,749 compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| GALD.SW - | HOLD | 0 @ CHF 160.099 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 160.099. The average price that GALD.SW shares were previous bought at was CHF 133.102. The current market price is 20.3% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 85,853 compared to the previous valuation of however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 262.174 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 262.174. The average price that GMAB.CO shares were previous bought at was DKK 213.077. The current market price is 23.0% higher than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 970,383 compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.87 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.87. The average price that GRF.MC shares were previous bought at was EUR 10.6961. The current market price is 1.6% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 22,779 compared to the previous valuation of Grifols SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 25.3171 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 25.3171. The average price that GSK.L shares were previous bought at was GBP 17.621. The current market price is 43.7% higher than average price they were purchased at. The value of the holding in GSK.L has increased by GBP 11,248,556 compared to the previous valuation of GlaxoSmithKline PLC however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |
| HIK.L - | HOLD | 0 @ GBP 17.7381 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 17.7381. The average price that HIK.L shares were previous bought at was GBP 22.1711. The current market price is -20.0% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 28,096 compared to the previous valuation of |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.58542 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.58542. The average price that HLN.L shares were previous bought at was GBP 4.39217. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 1,306,069 compared to the previous valuation of Haleon PLC however if the holding was sold on 2026-02-06 this would crystalise an overall loss. |